QuidelOrtho (QDEL)
(Real Time Quote from BATS)
$40.00 USD
+0.36 (0.91%)
Updated Apr 29, 2024 01:44 PM ET
5-Strong Sell of 5 5
A Value D Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
QDEL 40.00 +0.36(0.91%)
Will QDEL be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for QDEL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QDEL
QuidelOrtho's (QDEL) New Test to Offer Enhanced Opioid Testing
QuidelOrtho's (QDEL) QuickVue Gets FDA Nod for COVID Testing
QDEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
QuidelOrtho's (QDEL) New Approval to Aid Pre-eclampsia Diagnosis
QuidelOrtho (QDEL) Q4 Earnings and Sales Miss, Margins Fall
QuidelOrtho (QDEL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for QDEL
First Week of QDEL December 20th Options Trading
What's Driving Inspire Medical Systems Inc's Surprising 24% Stock Rally?
QuidelOrtho To Report First Quarter 2024 Financial Results
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP
Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against QuidelOrtho Corporation and Certain Executives